The issue of relapse in Philadelphia chromosome-positive ALL patients and how to combat this
Is inotuzumab ozogamicin with low-dose chemotherapy effective in treating ALL in elderly patients?
Ponatinib and its role in treating ALL
Treatment-free remission (TFR) – the safety of stopping treatment in chronic myeloid leukemia (CML)
Developments in CML over the past 30 years and where we are today